← FDA DRUG APPROVALS

FDA ANDA · ANDA063031

AMOXICILLIN

Sponsor: TEVA

APPLICATION
ANDA063031
TYPE
ANDA
ORIGINAL APPROVAL
1989-02-28
LATEST ACTION
1991-09-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 500MG · CAPSULE · ORAL

Approval history

1991-09-12Manufacturing (CMC) · Supplement 4AP
1991-09-12Manufacturing (CMC) · Supplement 2AP
1991-09-12Manufacturing (CMC) · Supplement 5AP
1990-09-06Manufacturing (CMC) · Supplement 3AP
1989-04-26Manufacturing (CMC) · Supplement 1AP
1989-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →